Your browser doesn't support javascript.
loading
Incidence and Risk Factors for Adrenal Crisis in Pediatric-onset Adrenal Insufficiency: A Prospective Study.
Hosokawa, Mayumi; Ichihashi, Yosuke; Sato, Yasunori; Shibata, Nao; Nagasaki, Keisuke; Ikegawa, Kento; Hasegawa, Yukihiro; Hamajima, Takashi; Nagamatsu, Fusa; Suzuki, Shigeru; Numakura, Chikahiko; Amano, Naoko; Sasaki, Goro; Nagahara, Keiko; Soneda, Shun; Ariyasu, Daisuke; Maeda, Miwako; Kamasaki, Hotaka; Aso, Keiko; Hasegawa, Tomonobu; Ishii, Tomohiro.
Afiliación
  • Hosokawa M; Japanese Multicenter Study for Adrenal Crisis (JMSAC), Tokyo 160-8582, Japan.
  • Ichihashi Y; Department of Pediatrics, Keio University School of Medicine, Tokyo 160-8582, Japan.
  • Sato Y; Department of Pediatrics, Saitama City Hospital, Saitama 336-8522, Japan.
  • Shibata N; Japanese Multicenter Study for Adrenal Crisis (JMSAC), Tokyo 160-8582, Japan.
  • Nagasaki K; Department of Pediatrics, Keio University School of Medicine, Tokyo 160-8582, Japan.
  • Ikegawa K; Department of Preventive Medicine and Public Health, Keio University School of Medicine, Tokyo 160-8582, Japan.
  • Hasegawa Y; Japanese Multicenter Study for Adrenal Crisis (JMSAC), Tokyo 160-8582, Japan.
  • Hamajima T; Department of Pediatrics, Niigata University Medical and Dental Hospital, Niigata 951-8520, Japan.
  • Nagamatsu F; Japanese Multicenter Study for Adrenal Crisis (JMSAC), Tokyo 160-8582, Japan.
  • Suzuki S; Department of Pediatrics, Niigata University Medical and Dental Hospital, Niigata 951-8520, Japan.
  • Numakura C; Japanese Multicenter Study for Adrenal Crisis (JMSAC), Tokyo 160-8582, Japan.
  • Amano N; Department of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Fuchu 183-8561, Japan.
  • Sasaki G; Japanese Multicenter Study for Adrenal Crisis (JMSAC), Tokyo 160-8582, Japan.
  • Nagahara K; Department of Endocrinology and Metabolism, Tokyo Metropolitan Children's Medical Center, Fuchu 183-8561, Japan.
  • Soneda S; Japanese Multicenter Study for Adrenal Crisis (JMSAC), Tokyo 160-8582, Japan.
  • Ariyasu D; Department of Endocrinology and Metabolism, Aichi Children's Health and Medical Center, Obu 474-8710, Japan.
  • Maeda M; Japanese Multicenter Study for Adrenal Crisis (JMSAC), Tokyo 160-8582, Japan.
  • Kamasaki H; Department of Pediatrics, Kumamoto University School of Medicine, Kumamoto 860-8556, Japan.
  • Aso K; Japanese Multicenter Study for Adrenal Crisis (JMSAC), Tokyo 160-8582, Japan.
  • Hasegawa T; Department of Pediatrics, Asahikawa Medical University, Asahikawa 078-8510, Japan.
  • Ishii T; Japanese Multicenter Study for Adrenal Crisis (JMSAC), Tokyo 160-8582, Japan.
J Clin Endocrinol Metab ; 109(8): e1602-e1607, 2024 Jul 12.
Article en En | MEDLINE | ID: mdl-38128002
ABSTRACT
CONTEXT Adrenal crisis (AC) is a life-threatening complication that occurs during follow-up of patients with adrenal insufficiency (AI). No prospective study has thoroughly investigated AC in children with primary and secondary AI.

OBJECTIVE:

This work aimed to determine the incidence and risk factors for AC in patients with pediatric-onset AI.

METHODS:

This multicenter, prospective cohort study conducted in Japan enrolled patients diagnosed with AI at age ≤15 years. The incidence of AC was calculated as events per person-year (PY), and risk factors for AC were assessed using Poisson regression multivariable analysis.

RESULTS:

The study population comprised 349 patients (164 male, 185 female) with a total follow-up of 961 PY. The median age at enrollment was 14.3 years (interquartile range [IQR] 8.5-21.2 years), and the median follow-up was 2.8 years (IQR 2.2-3.3 years). Of these patients, 213 (61%) had primary AI and 136 (39%) had secondary AI. Forty-one AC events occurred in 31 patients during the study period. The calculated incidence of AC was 4.27 per 100 PY (95% CI, 3.15-5.75). Poisson regression analysis identified younger age at enrollment (relative risk [RR] 0.93; 95% CI, 0.89-0.97) and increased number of infections (RR 1.17; 95% CI, 1.07-1.27) as significant risk factors. Female sex (RR 0.99; 95% CI, 0.53-1.86), primary AI (RR 0.65; 95% CI, 0.30-1.41), or equivalent dosage of hydrocortisone per square meter of body area (RR 1.02; 95% CI, 0.96-1.08) was not a significant risk factor.

CONCLUSION:

A substantial proportion of patients with pediatric-onset AI experience AC. Younger age and an increased number of infections are independent risk factors for developing AC in these patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Insuficiencia Suprarrenal Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: J Clin Endocrinol Metab Año: 2024 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Insuficiencia Suprarrenal Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male País/Región como asunto: Asia Idioma: En Revista: J Clin Endocrinol Metab Año: 2024 Tipo del documento: Article País de afiliación: Japón